Inari Medical Inc
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-… Read more
Inari Medical Inc (NARI) - Net Assets
Latest net assets as of September 2024: $434.76 Million USD
Based on the latest financial reports, Inari Medical Inc (NARI) has net assets worth $434.76 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($697.24 Million) and total liabilities ($262.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $434.76 Million |
| % of Total Assets | 62.35% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 27.93 |
Inari Medical Inc - Net Assets Trend (2018–2023)
This chart illustrates how Inari Medical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Inari Medical Inc (2018–2023)
The table below shows the annual net assets of Inari Medical Inc from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $464.91 Million | +11.49% |
| 2022-12-31 | $417.00 Million | +74.33% |
| 2021-12-31 | $239.21 Million | +19.45% |
| 2020-12-31 | $200.25 Million | +611.59% |
| 2019-12-31 | $-39.14 Million | +0.76% |
| 2018-12-31 | $-39.45 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Inari Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 836247400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $58.00K | 0.01% |
| Other Comprehensive Income | $8.88 Million | 1.91% |
| Other Components | $504.45 Million | 108.51% |
| Total Equity | $464.91 Million | 100.00% |
Inari Medical Inc Competitors by Market Cap
The table below lists competitors of Inari Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Urban Outfitters Inc
NASDAQ:URBN
|
$4.27 Billion |
|
Edenred SA
PA:EDEN
|
$4.27 Billion |
|
Shenzhen Woer Heat-Shrinkable Material Co Ltd
SHE:002130
|
$4.28 Billion |
|
Tubize-Fin
BR:TUB
|
$4.28 Billion |
|
Ono Pharmaceutical Co. Ltd
PINK:OPHLF
|
$4.26 Billion |
|
Skyline Corporation
NYSE:SKY
|
$4.26 Billion |
|
Mueller Water Products
NYSE:MWA
|
$4.26 Billion |
|
Alkermes Plc
NASDAQ:ALKS
|
$4.26 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Inari Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 417,002,000 to 464,910,000, a change of 47,908,000 (11.5%).
- Net loss of 1,636,000 reduced equity.
- Share repurchases of 9,574,000 reduced equity.
- New share issuances of 9,921,000 increased equity.
- Other comprehensive income increased equity by 8,036,000.
- Other factors increased equity by 41,161,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.64 Million | -0.35% |
| Share Repurchases | $9.57 Million | -2.06% |
| Share Issuances | $9.92 Million | +2.13% |
| Other Comprehensive Income | $8.04 Million | +1.73% |
| Other Changes | $41.16 Million | +8.85% |
| Total Change | $- | 11.49% |
Book Value vs Market Value Analysis
This analysis compares Inari Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.77x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.88 | $79.97 | x |
| 2019-12-31 | $-0.81 | $79.97 | x |
| 2020-12-31 | $3.88 | $79.97 | x |
| 2021-12-31 | $4.30 | $79.97 | x |
| 2022-12-31 | $7.89 | $79.97 | x |
| 2023-12-31 | $8.19 | $79.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Inari Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.33%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 1.45x
- Recent ROE (-0.35%) is below the historical average (0.60%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -148.67% | 0.25x | 0.00x | $-6.21 Million |
| 2019 | 0.00% | -3.73% | 1.15x | 0.00x | $2.01 Million |
| 2020 | 6.89% | 9.87% | 0.65x | 1.07x | $-6.24 Million |
| 2021 | 4.11% | 3.55% | 0.89x | 1.30x | $-14.08 Million |
| 2022 | -7.02% | -7.63% | 0.76x | 1.21x | $-70.97 Million |
| 2023 | -0.35% | -0.33% | 0.73x | 1.45x | $-48.13 Million |
Industry Comparison
This section compares Inari Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Inari Medical Inc (NARI) | $434.76 Million | 0.00% | 0.60x | $4.27 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |